201 related articles for article (PubMed ID: 3940209)
1. Expression of GD2 ganglioside by untreated primary human neuroblastomas.
Wu ZL; Schwartz E; Seeger R; Ladisch S
Cancer Res; 1986 Jan; 46(1):440-3. PubMed ID: 3940209
[TBL] [Abstract][Full Text] [Related]
2. New method for quantitative analysis of GD2 ganglioside in plasma of neuroblastoma patients.
Czaplicki D; Horwacik I; Kowalczyk A; Wieczorek A; Bolek-Marzec K; Balwierz W; Kozik A; Rokita H
Acta Biochim Pol; 2009; 56(3):423-31. PubMed ID: 19724779
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxicity of L-cycloserine against human neuroblastoma and medulloblastoma cells is associated with the suppression of ganglioside expression.
Cinatl J; Cinatl J; Kotchetkov R; Pouckova P; Vogel JU; Rabenau H; Michaelis M; Kornhuber B
Anticancer Res; 1999; 19(6B):5349-54. PubMed ID: 10697560
[TBL] [Abstract][Full Text] [Related]
4. Shedding of GD2 ganglioside by human neuroblastoma.
Ladisch S; Wu ZL; Feig S; Ulsh L; Schwartz E; Floutsis G; Wiley F; Lenarsky C; Seeger R
Int J Cancer; 1987 Jan; 39(1):73-6. PubMed ID: 3539825
[TBL] [Abstract][Full Text] [Related]
5. Disialoganglioside G(D2) loss following monoclonal antibody therapy is rare in neuroblastoma.
Kramer K; Gerald WL; Kushner BH; Larson SM; Hameed M; Cheung NK
Clin Cancer Res; 1998 Sep; 4(9):2135-9. PubMed ID: 9748131
[TBL] [Abstract][Full Text] [Related]
6. [The immunological cellular phenotype and the prognosis in neuroblastoma in children].
Novikov AM; Blinov VM; Bukhny AF; Bassalyk LS
Vopr Onkol; 1990; 36(6):693-7. PubMed ID: 2378089
[TBL] [Abstract][Full Text] [Related]
7. Neuroblastoma cells can be classified according to glycosphingolipid expression profiles identified by liquid chromatography-tandem mass spectrometry.
Kaneko T; Okita H; Nakajima H; Iijima K; Ogasawara N; Miyagawa Y; Katagiri YU; Nakagawa A; Kiyokawa N; Sato T; Fujimoto J
Int J Oncol; 2010 Nov; 37(5):1279-88. PubMed ID: 20878075
[TBL] [Abstract][Full Text] [Related]
8. Frequency of ALK and GD2 Expression in Neuroblastoma.
Aygün Z; Batur Ş; Emre Ş; Celkan T; Özman O; Comunoglu N
Fetal Pediatr Pathol; 2019 Aug; 38(4):326-334. PubMed ID: 30955398
[No Abstract] [Full Text] [Related]
9. The GD2-specific 14G2a monoclonal antibody induces apoptosis and enhances cytotoxicity of chemotherapeutic drugs in IMR-32 human neuroblastoma cells.
Kowalczyk A; Gil M; Horwacik I; Odrowaz Z; Kozbor D; Rokita H
Cancer Lett; 2009 Aug; 281(2):171-82. PubMed ID: 19339105
[TBL] [Abstract][Full Text] [Related]
10. Neuroblastomas of infancy exhibit a characteristic ganglioside pattern.
Kaucic K; Etue N; LaFleur B; Woods W; Ladisch S
Cancer; 2001 Feb; 91(4):785-93. PubMed ID: 11241247
[TBL] [Abstract][Full Text] [Related]
11. Induction of IgG antibodies against the GD2 carbohydrate tumor antigen by vaccination with peptide mimotopes.
Riemer AB; Förster-Waldl E; Brämswig KH; Pollak A; Zielinski CC; Pehamberger H; Lode HN; Scheiner O; Jensen-Jarolim E
Eur J Immunol; 2006 May; 36(5):1267-74. PubMed ID: 16568495
[TBL] [Abstract][Full Text] [Related]
12. Selection of novel peptide mimics of the GD2 ganglioside from a constrained phage-displayed peptide library.
Horwacik I; Czaplicki D; Talarek K; Kowalczyk A; Bolesta E; Kozbor D; Rokita H
Int J Mol Med; 2007 May; 19(5):829-39. PubMed ID: 17390090
[TBL] [Abstract][Full Text] [Related]
13. Incorporation, remodeling and re-expression of exogenous gangliosides in human cancer cell lines in vitro and in vivo.
Nishio M; Furukawa K
Nagoya J Med Sci; 2004 May; 67(1-2):35-44. PubMed ID: 15279066
[TBL] [Abstract][Full Text] [Related]
14. Treatment of neuroblastoma meningeal carcinomatosis with intrathecal application of alpha-emitting atomic nanogenerators targeting disialo-ganglioside GD2.
Miederer M; McDevitt MR; Borchardt P; Bergman I; Kramer K; Cheung NK; Scheinberg DA
Clin Cancer Res; 2004 Oct; 10(20):6985-92. PubMed ID: 15501978
[TBL] [Abstract][Full Text] [Related]
15. Biological stratification of human neuroblastoma by complex "B" pathway ganglioside expression.
Hettmer S; Malott C; Woods W; Ladisch S; Kaucic K
Cancer Res; 2003 Nov; 63(21):7270-6. PubMed ID: 14612523
[TBL] [Abstract][Full Text] [Related]
16. DNA vaccine expressing the mimotope of GD2 ganglioside induces protective GD2 cross-reactive antibody responses.
Bolesta E; Kowalczyk A; Wierzbicki A; Rotkiewicz P; Bambach B; Tsao CY; Horwacik I; Kolinski A; Rokita H; Brecher M; Wang X; Ferrone S; Kozbor D
Cancer Res; 2005 Apr; 65(8):3410-8. PubMed ID: 15833876
[TBL] [Abstract][Full Text] [Related]
17. Combined automatic immunological and molecular cytogenetic analysis allows exact identification and quantification of tumor cells in the bone marrow.
Méhes G; Luegmayr A; Ambros IM; Ladenstein R; Ambros PF
Clin Cancer Res; 2001 Jul; 7(7):1969-75. PubMed ID: 11448912
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibodies to gamma-interferon treated LAN-1 cells detect modulation of ganglioside GD2 exposure on human neuroblastoma cells.
Gross N; Beck D; Portoukalian J; Carrel S; Favre S
Anticancer Res; 1989; 9(6):1519-24. PubMed ID: 2516714
[TBL] [Abstract][Full Text] [Related]
19. Distribution of disialoganglioside GD2-antigen and binding of anti-GD2 antibodies on spheroids of neuroblastoma cell line.
Heiss P; Bermatz S; Wehnes H; Heinzmann U; Senekowitsch-Schmidtke R
Anticancer Res; 1997; 17(4B):3145-7. PubMed ID: 9329622
[TBL] [Abstract][Full Text] [Related]
20. Lacking immunocytological GD2 expression in neuroblastoma: report of 3 cases.
Schumacher-Kuckelkorn R; Hero B; Ernestus K; Berthold F
Pediatr Blood Cancer; 2005 Aug; 45(2):195-201. PubMed ID: 15800908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
